United States > Products & Services > Health Care > Tegaderm™ CHG > Product Information > Evidence > Reduces Skin Flora
Reduces Skin Flora
Shown to be better than BIOPATCH® at reducing skin flora on healthy adult subjects for up to 10 days.
A Novel Integrated Chlorhexidine-impregnated Transparent Dressing for Prevention of Vascular Catheter-related Bloodstream Infection: A Prospective Comparative Study in Healthy Subjects
Suppresses Regrowth
Proven more effective than BIOPATCH® at preventing regrowth of skin flora on healthy adult subjects at day 7.
Tegaderm™ CHG Dressings maintained significantly lower counts than BIOPATCH® or control dressings after 7 days on healthy adult subjects.
Suppression of Regrowth of Normal Skin Flora under Chlorhexidine Gluconate Dressings Applied to CHG-Prepped Skin
Provides Continuous Protection
The reservoir of CHG within the gel pad was as available and as effective at Day 10 as Day 1.
Antimicrobial Activity of a CHG-Impregnated Gel Pad for IV Site Protection
See all of the evidence for yourself.
Request your copy of the Tegaderm™ CHG Dressing Clinical Evidence Package.
3M™ Tegaderm™ CHG Dressings have not been studied in a randomized clinical study as to their effectiveness in preventing CRBSIs. BIOPATCH® is a registered trademark of ETHICON, INC.
Request your copy of the Tegaderm™ CHG Dressing Clinical Evidence Package and register to receive future product and educational program updates.
Request more information about Independent individual facility experiences and their outcomes.
Purchasing Decision-Makers
Interactive Application Guide
Application & Removal Videos
AHRMM’s 49th Annual Conference & Exhibition August 7-10, 2011, Boston, MA
more >
Learn more about IV site care, infection prevention strategies and other topics. CEUs available. >